Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Key advances in ALL and AML

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 07.08.18
Views: 772

Dr Martin S. Tallman - Moffitt Cancer Center, Tampa, USA

Dr Martin Tallman speaks to ecancer at BEST OF ASCO® 2018 MIAMI SYMPOSIUM about acute myeloid leukaemia and acute lymphoblastic leukaemia.

He talks about the high mutation rate, and how this effects treatment.

From this he discusses some of the treatment options and survival rates for these.

Related videos

follow us

Donate to ecancer

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation